Top compounds associated with response to STARD9


Feature Type Standardized
Nominal ANOVA
mRNA AZD-2281 CTRPv2 pan-cancer AAC 0.2 2e-07
mRNA alisertib CTRPv2 pan-cancer AAC 0.18 2e-07
mRNA navitoclax:PLX-4032 (1:1 mol/mol) CTRPv2 pan-cancer AAC 0.21 2e-07
mRNA BRD-K27188169:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC 0.29 3e-07
mRNA KPT185 CTRPv2 pan-cancer AAC 0.21 4e-07
mRNA navitoclax:piperlongumine (1:1 mol/mol) CTRPv2 pan-cancer AAC 0.2 5e-07
mRNA Genentech Cpd 10 GDSC1000 pan-cancer AAC 0.17 1e-06
mRNA Cetuximab GDSC1000 pan-cancer AAC -0.18 1e-06
mRNA Cerulenin CTRPv2 pan-cancer AAC 0.18 1e-06
mRNA chlorambucil CTRPv2 pan-cancer AAC 0.17 2e-06
Download CSV